Sermorelin

FDA Approved

Sermorelin (GRF 1-29)

Category
Growth Hormone
Aliases
GRF 1-29, Geref
Administration
Subcutaneous injection

Documented benefits

Tier 1 · Peer-reviewed / regulatory

Benefit categories

Growth Hormone

Sermorelin's defining research application — the shortest GHRH fragment that retains full biological activity.

Growth hormone stimulation

One of the few compounds in this category to have held formal FDA approval (as Geref) for this exact purpose.

IGF-1 elevation

Stimulates natural, pulsatile growth hormone release, which drives IGF-1 production while preserving the body's normal feedback regulation.